Table of Contents Author Guidelines Submit a Manuscript
Depression Research and Treatment
Volume 2011 (2011), Article ID 470985, 7 pages
http://dx.doi.org/10.1155/2011/470985
Research Article

Predictors of Time to Relapse/Recurrence after Electroconvulsive Therapy in Patients with Major Depressive Disorder: A Population-Based Cohort Study

1Department of Psychiatry, Örebro County Council, Örebro University Hospital, 701 85 Örebro, Sweden
2Psychiatric Research Centre, School of Health and Medical Sciences, Örebro University, 701 82 Örebro, Sweden
3Department of Neuroscience, Psychiatry, Uppsala University, 751 85 Uppsala, Sweden

Received 2 August 2011; Accepted 16 September 2011

Academic Editor: Takeshi Terao

Copyright © 2011 Axel Nordenskjöld et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Sobocki, I. Lekander, F. Borgström, O. Ström, and B. Runeson, “The economic burden of depression in Sweden from 1997 to 2005,” European Psychiatry, vol. 22, no. 3, pp. 146–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Angst and M. Preisig, “Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985,” Schweizer Archiv fur Neurologie und Psychiatrie, vol. 146, no. 1, pp. 5–16, 1995. View at Google Scholar
  3. SBU, Treatment of Depression (Behandling av Depressionssjukdomar), The Swedish Council on Technology Assessment in Health Care, Stockholm, Sweden, 2004.
  4. M. Huuhka, L. Korpisammal, R. Haataja, and E. Leinonen, “One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants,” Journal of ECT, vol. 20, no. 3, pp. 179–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Stoudemire, C. D. Hill, S. T. Dalton, and M. G. Marquardt, “Rehospitalization rates in older depressed adults after antidepressant and electroconvulsive therapy treatment,” Journal of the American Geriatrics Society, vol. 42, no. 12, pp. 1282–1285, 1994. View at Google Scholar · View at Scopus
  6. American Psychiatric Association, Committee on Electroconvulsive Therapy., Weiner RD. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: a Task Force Report of the American Psychiatric Association, American Psychiatric Association, Washington, DC, USA, 2nd edition, 2001.
  7. H. A. Sackeim, R. F. Haskett, B. H. Mulsant et al., “Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial,” JAMA, vol. 285, no. 10, pp. 1299–1307, 2001. View at Google Scholar · View at Scopus
  8. C. H. Kellner, R. G. Knapp, G. Petrides et al., “Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE),” Archives of General Psychiatry, vol. 63, no. 12, pp. 1337–1344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Tew Jr., B. H. Mulsant, R. F. Haskett, P. Joan, A. E. Begley, and H. A. Sackeim, “Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment,” Annals of Clinical Psychiatry, vol. 19, no. 1, pp. 1–4, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Andrade, A. I. Nelson, and M. Fink, “ECT in the management of major depression: implications of recent research,” The World Journal of Biological Psychiatry, vol. 4, no. 3, pp. 139–140, 2003. View at Google Scholar · View at Scopus
  11. K. Komossa, A. M. Depping, A. Gaudchau, W. Kissling, and S. Leucht, “Second-generation antipsychotics for major depressive disorder and dysthymia,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD008121, 2010. View at Google Scholar
  12. J. Chen, K. Gao, and D. E. Kemp, “Second-generation antipsychotics in major depressive disorder: update and clinical perspective,” Current Opinion in Psychiatry, vol. 24, no. 1, pp. 10–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. C. Ten Doesschate, C. L. H. Bockting, M. W. J. Koeter, and A. H. Schene, “Prediction of recurrence in recurrent depression: a 5.5-year prospective study,” Journal of Clinical Psychiatry, vol. 71, no. 8, pp. 984–991, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. A. Sackeim, J. Prudic, D. P. Devanand, P. Decina, B. Kerr, and S. Malitz, “The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression,” Journal of Clinical Psychopharmacology, vol. 10, no. 2, pp. 96–104, 1990. View at Google Scholar · View at Scopus
  15. A. A. Nierenberg, M. M. Husain, M. H. Trivedi et al., “Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report,” Psychological Medicine, vol. 40, no. 1, pp. 41–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. L. Davis, S. R. Wisniewski, R. H. Howland et al., “Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes,” Drug and Alcohol Dependence, vol. 107, no. 2-3, pp. 161–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. H. Howland, A. John Rush, S. R. Wisniewski et al., “Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome,” Drug and Alcohol Dependence, vol. 99, no. 1–3, pp. 248–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. McGrath, J. W. Stewart, F. M. Quitkin et al., “Predictors of relapse in a prospective study of fluoxetine treatment of major depression,” American Journal of Psychiatry, vol. 163, no. 9, pp. 1542–1548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Guy, in ECDEU Assessment Manual for Psychopharmacology, National Institute of Health, Psychopharmacology Research Branch, Rockville, Md, USA, 1976.
  20. P. Svanborg and M. Åsberg, “A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Åsberg Depression Rating Scale (MADRS),” Journal of Affective Disorders, vol. 64, no. 2-3, pp. 203–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. H. A. Sackeim, E. M. Dillingham, J. Prudic et al., “Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects,” Archives of General Psychiatry, vol. 66, no. 7, pp. 729–737, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Nelson and G. I. Papakostas, “Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials,” American Journal of Psychiatry, vol. 166, no. 9, pp. 980–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. D. Dhondt, A. T. F. Beekman, D. J. Deeg, and W. van Tilburg, “Iatrogenic depression in the elderly. Results from a community-based study in the Netherlands,” Social Psychiatry and Psychiatric Epidemiology, vol. 37, no. 8, pp. 393–398, 2002. View at Publisher · View at Google Scholar · View at Scopus